LA JOLLA, Calif., March 4, 2021 /PRNewswire-PRWeb/ -- Gateway
Genomics, leading developer of direct-to-consumer genetic tests
that give families insight into their future children, achieved a
milestone of over 1,000 distributors of its SneakPeek Clinical test
across the US, UK, and Canada.
This number represents a doubling of locations since this time last
year.
"While we did see a slight slowdown in sales volume around
March 2020 as fewer women chose to
visit clinical locations to take the test, interest in signing on
to be providers remained steady," says Gateway Genomics CEO,
Chris Jacob. "Providers saw the
immense value of adding an accurate, affordable early fetal sex
test to their offerings. Establishing a relationship with a new
client as early as 8 weeks into pregnancy proved to be a valuable
touchpoint that opened the gate for future services and
products."
From a survey to over 35,000 customers, it was found that 55% of
SneakPeek Early Gender DNA Test users also take a non-invasive
prenatal test (NIPT) later in pregnancy to screen for chromosomal
abnormalities. Nearly 80% of SneakPeek customers want to know the
gender of their baby to guide shopping choices and make product
purchases. "Parents in the first trimester are interested in
learning as much as they can about their babies, as well as
ensuring they have the right products and services to help both mom
and baby have a healthy, comfortable pregnancy," continues Mr.
Jacob. "We saw this recognized by a diverse range of providers, and
signups to become distributors increased linearly throughout all of
2020. Since March 2020, test volume
has rebounded and we see this sales channel continuing to grow
rapidly in the upcoming year."
The SneakPeek Early Gender DNA Test by Gateway Genomics is a
fetal sex test that can be taken at just 8 weeks into pregnancy
with 99.9% accuracy. The test is available in two ways: An At-Home
version that can be ordered from the company's ecommerce website
and is delivered through the mail, and a Clinical version that is
offered in over 1,000 participating clinical locations and labs in
the US, UK, and Canada. The two
channels give moms the choice of taking the test on their own, from
the comfort of home, or visiting a clinic to have blood drawn by a
phlebotomist. Both can return gender results in as little as 48
hours.
In 2020, Gateway Genomics ranked #296 in the Inc. 5000 list of
fastest-growing private companies in the U.S., #22 in the Health
sector. In 2020's Inc. 5000 California list, the company was ranked
the 17th fastest-growing private company in the state, and #1 in
the Health sector. Gateway Genomics' principal product, SneakPeek
Gender, is an easy-to-use DNA test that lets parents know the
gender of their babies as early as 8 weeks into pregnancy, with
99.9% accuracy.
About Gateway Genomics
Gateway Genomics is a personal genomics company with the mission
to develop leading-edge genetic tests that give families a new
level of understanding about their future children. Since
inception, more than 300,000 SneakPeek DNA tests have been provided
to help new parents bond with their babies, make plans, and connect
with friends and family around them. Gateway Genomics is located in
La Jolla, CA.
Media Contact
Angela Shue, Gateway Genomics,
8582554330, angela@gatewaygenomics.org
SOURCE Gateway Genomics